+ Translate

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

, : Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. New England Journal of Medicine 356(18): 1809-1822

BACKGROUND:A single infusion of intravenous zoledronic acid decreases bone turnover and improves bone density at 12 months in postmenopausal women with osteoporosis. We assessed the effects of annual infusions of zoledronic acid on fracture risk during a 3-year period.METHODS:In this double-blind, placebo-controlled trial, 3889 patients (mean age, 73 years) were randomly assigned to receive a single 15-minute infusion of zoledronic acid (5 mg) and 3876 were assigned to receive placebo at baseline, at 12 months, and at 24 months; the patients were followed until 36 months. Primary end points were new vertebral fracture (in patients not taking concomitant osteoporosis medications) and hip fracture (in all patients). Secondary end points included bone mineral density, bone turnover markers, and safety outcomes.RESULTS:Treatment with zoledronic acid reduced the risk of morphometric vertebral fracture by 70% during a 3-year period, as compared with placebo (3.3% in the zoledronic-acid group vs. 10.9% in the placebo group; relative risk, 0.30; 95% confidence interval [CI], 0.24 to 0.38) and reduced the risk of hip fracture by 41% (1.4% in the zoledronic-acid group vs. 2.5% in the placebo group; hazard ratio, 0.59; 95% CI, 0.42 to 0.83). Nonvertebral fractures, clinical fractures, and clinical vertebral fractures were reduced by 25%, 33%, and 77%, respectively (P < 0.001 for all comparisons). Zoledronic acid was also associated with a significant improvement in bone mineral density and bone metabolism markers. Adverse events, including change in renal function, were similar in the two study groups. However, serious atrial fibrillation occurred more frequently in the zoledronic acid group (in 50 vs. 20 patients, P < 0.001).CONCLUSIONS:A once-yearly infusion of zoledronic acid during a 3-year period significantly reduced the risk of vertebral, hip, and other fractures.

(PDF same-day service: $19.90)

Order PDF Full Text


Click here to order any other PDF Full Text

Accession: 013259105

PMID: 17476007

DOI: 10.1056/NEJMoa067312

PDF Full Text: Submit

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Other references

Baccin, Carlos, E.; Montenegro, Maria, A.; Mourao, Guilherme, S., 2004: Thoracic aorta dissection associated with aberrant right subclavian artery: Treatment with endovascular stent-graft placement. Dissecting aneurysm is the condition produced by separation of the layers of the arterial wall by circulating blood. Although rare, the coexistence of aortic dissection and aberrant right subclavian artery may be catastrophic. In this study we rep...

Hayes, Wilson C.; Bouxsein, Mary L., 1997: Biomechanics of cortical and trabecular bone Implications for assessment of fracture risk. Mow, V C , Hayes, W C Basic orthopaedic biomechanics, Second edition : 69-111

Fröbius, A.C.; Seaver, E.C., 2006: Capitella sp. I homeobrain-like, the first lophotrochozoan member of a novel paired-like homeobox gene family. The paired-like class of homeobox genes contains numerous distinct families, many of which have been implicated in a variety of developmental functions. We report the isolation and expression of a gene with high similarity to Drosophila melanogast...

Bobko, Christine M., 1996: Detection and treatment of a possible new disease syndrome in a captive black rhinoceros (Diceros bicornis). American Zoo and Aquarium Association Regional Conference Proceedings, 452-456

Schwartz, A., 1964: The effects of basic proteins on active transport enzyme systems. Int Congr Biochem 6(8): 666

Liu, Su Yan; Gonzalez, Frank J., 1995: Role of the liver-enriched transcription factor HNF-1-alpha in expression of the CYP2E1 gene. The role of the trans-acting factor HNF-1-alpha in activating CYP2E1 gene expression was confirmed by transient co-transfection of an HNF-1-alpha expression plasmid and the CYP2E1 promoter fused to the chloramphenicol acetyl transferase (CAT) repo...

Naruse, M., 1975: Application of nucleic acid related compounds for drugs. The application of nucleic acid analogues to medical treatment is reviewed. They are used as CNS and metabolic agents for circulatory and urinary organs, antitumor agents, antivirotics and interferon inducers. Of the natural xanthine derivitives w...

Bajetta, E.; Di Bartolomeo, M.; Buzzoni, R.; Mariani, L.; Zilembo, N.; Ferrario, E.; Lo Vullo, S.; Aitini, E.; Isa, L.; Barone, C.; Jacobelli, S.; Recaldin, E.; Pinotti, G.; Iop, A., 2007: Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study. This randomised phase II study evaluates the safety and efficacy profile of uracil/tegafur/leucovorin combined with irinotecan (TEGAFIRI) or with oxaliplatin (TEGAFOX). One hundred and forty-three patients with measurable, non-resectable metastat...

Schenck, N. C.; Crall, J. M., 1957: Five year summary on fungicidal control of watermelon foliage diseases. Maneb and zineb were superior in over-all control of the 4 predominant leaf diseases, downy mildew (Pseudoperonospora cubensis), gummy stem blight (Myco-sphaerella citrulilna), leaf spot (Cercospora citrullina) and anthracnose (Colletotrichum lage...

Beach, F. A., 1963: Reproductive anatomy and mating behavior of an intersex rat. In the intersexual animal the clitoris was greatly hypertrophied and contained an "os penis". Immediately ventral to this structure was a blind pouch giving the appearance of an infantile vagina. Irregular periods of Cornification appear...